These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32070355)

  • 1. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan.
    Mohamed AO; Hussien M; Mohamed A; Suliman A; Elkando NS; Abdelbagi H; Malik EM; Abdelraheem MH; Hamid MMA
    Malar J; 2020 Feb; 19(1):78. PubMed ID: 32070355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
    Bakhiet AMA; Abdelraheem MH; Kheir A; Omer S; Gismelseed L; Abdel-Muhsin AA; Naiem A; Al Hosni A; Al Dhuhli A; Al Rubkhi M; Al-Hamidhi S; Gadalla A; Mukhtar M; Sultan AA; Babiker HA
    Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):693-700. PubMed ID: 31369106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
    Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
    Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
    Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
    Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
    Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
    Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
    Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
    Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.
    Diakité SAS; Traoré K; Sanogo I; Clark TG; Campino S; Sangaré M; Dabitao D; Dara A; Konaté DS; Doucouré F; Cissé A; Keita B; Doumbouya M; Guindo MA; Toure MB; Sogoba N; Doumbia S; Awandare GA; Diakité M
    Malar J; 2019 Nov; 18(1):361. PubMed ID: 31718631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant
    Wang X; Zhang X; Chen H; Zhang J; Lu Q; Ruan W; Ling F
    Microbiol Spectr; 2022 Oct; 10(5):e0052822. PubMed ID: 36106887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of Antimalarial Drugs on
    Hemming-Schroeder E; Umukoro E; Lo E; Fung B; Tomás-Domingo P; Zhou G; Zhong D; Dixit A; Atieli H; Githeko A; Vardo-Zalik A; Yan G
    Am J Trop Med Hyg; 2018 Mar; 98(3):692-699. PubMed ID: 29363453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.
    Kuesap J; Suphakhonchuwong N; Kalawong L; Khumchum N
    Korean J Parasitol; 2022 Apr; 60(2):109-116. PubMed ID: 35500892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.
    Singh A; Singh MP; Ali NA; Poriya R; Rajvanshi H; Nisar S; Bhandari S; Sahu RS; Jayswar H; Mishra AK; Das A; Kaur H; Anvikar AR; Escalante AA; Lal AA; Bharti PK
    Malar J; 2023 Dec; 22(1):375. PubMed ID: 38072967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies.
    Adam M; Nahzat S; Kakar Q; Assada M; Witkowski B; Tag Eldin Elshafie A; Abuobaida D; Safi N; Khan MA; Nagi M; Mustafa SA; Kohestani K; Muhammad J; Khim N; Al-Hadi M; Elfaki TM; Habib MN; Khairy AKA; Hamid H; Uddin Z; Amer Y; Hassan AH; Elhag MS; Sediqi AW; Kakar I; Abdul-Ghani R; Amran JGH; Abdallrahim TA; Tamim MS; Aljasari A; Rasmussen C; Azkoul L; Warsame M
    Trop Med Int Health; 2023 Oct; 28(10):817-829. PubMed ID: 37705047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.